Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-212,200
Closed -$3.12M 2330
2025
Q3
$3.12M Buy
212,200
+17,000
+9% +$173K ﹤0.01% 1608
2025
Q2
$1.92M Sell
195,200
-10,300
-5% -$85.3K ﹤0.01% 1826
2025
Q1
$1.49M Buy
205,500
+43,900
+27% +$384K ﹤0.01% 1931
2024
Q4
$1.26M Buy
161,600
+21,100
+15% +$174K ﹤0.01% 2096
2024
Q3
$1.04M Hold
140,500
﹤0.01% 2199
2024
Q2
$1.13M Sell
140,500
-6,700
-5% -$59.8K ﹤0.01% 2114
2024
Q1
$1.71M Buy
147,200
+4,400
+3% +$48.7K ﹤0.01% 1927
2023
Q4
$1.6M Buy
142,800
+30,700
+27% +$282K ﹤0.01% 1977
2023
Q3
$1.73M Buy
112,100
+1,100
+1% +$18.5K ﹤0.01% 1929
2023
Q2
$2.1M Buy
+111,000
New +$1.95M ﹤0.01% 1855

Other funds holding ETNB

Swiss National Bank's ETNB Position: Q4 2025 in Review

Swiss National Bank sold out of 89bio (ETNB) in Q4 2025, closing a stake of 212,200 shares — an estimated $3.12M sold.

Swiss National Bank first reported a position in ETNB in Q2 2023 and held it in 10 quarters. The position peaked at $3.12M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Swiss National Bank reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Swiss National Bank sold 212,200 89bio shares in Q4 2025, an estimated $3.12M.
  • Swiss National Bank first reported a position in 89bio in Q2 2023 and held it in 10 quarters.
  • Swiss National Bank's 89bio position peaked at $3.12M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Swiss National Bank's 13F filing for Q4 2025, filed 12 Feb 2026.